NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 203

Clinical Trials Chronic Pain Data Treatment 203

Project CBD

JANUARY 24, 2019

Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Endometriosis is a poorly-understood condition causing severe chronic pain and alterations in a woman’s menstrual cycle. Cannabinoid crystals.

Research and Development 256

Research and Development Chronic Pain Cannabinoids Treatment 256

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 127

Data Research and Development Patients Strains 127

NORML

MARCH 20, 2019

NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events. But it is not evidence that marijuana in any way causes the condition.

THC 280

THC Data Cannabis Events 280

Project CBD

JUNE 20, 2023

One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). The endocannabinoid system is widely distributed throughout the gastrointestinal system, including not only CB1 and CB2 cannabinoid receptors but also other cannabinoid targets like PPARs, GPR55, and TRPV1.

Cannabinoids 212

Cannabinoids Patients Treatment Conditions 212

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

The Cannigma

SEPTEMBER 4, 2024

But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. absorption), at least with rectal insertion.

Data 98

Data CBD Collective Cannabinoids 98

The Cannigma

DECEMBER 20, 2021

Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling.

Terpenes 145

Terpenes Cannabinoids Topical Research and Development 145

MedicalJane

JUNE 12, 2020

All of the participants self-reported that they or their dependent patient had a diagnosed health condition at the time of the baseline assessment. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Study Findings.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

NORML

AUGUST 26, 2019

The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. How did getting rid of qualifying conditions make things easier for Virginia’s patients and the legislature? So, we set about these two objectives, one being to add additional conditions.

Marijuana 226

Marijuana Legalization Programs Oil 226

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Project CBD

FEBRUARY 27, 2023

Recently published papers — a series of reviews, two human studies, and an animal study — only bolster the case that cannabis can help those suffering from this confounding condition. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”

THC 144

THC CBD Clinical Trials Sleep 144

The Cannigma

OCTOBER 21, 2021

More than likely, the effects of cannabinoids like CBD and THC are altered during the ketogenic diet, but unfortunately there has been very little research on this topic. This would hypothetically correlate with the altered effects of cannabinoids like THC and CBD, but the study did not look at that. As per usual, more data is needed.

Cannabinoids 145

Cannabinoids Edibles Conditions Data 145

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

Cannabis Law Report

NOVEMBER 12, 2021

Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Cheri

APRIL 1, 2022

We know that cannabinoids like THC and CBD are fat soluable. In other words, ketogenesis seemed to increase the responsiveness of the ECS and the overall number of cannabinoid receptors within the intestines. Not everyone encounters this annoying condition, but many people starting a keto diet do. Read more here.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

FloridaMarijuana.net

SEPTEMBER 24, 2018

The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.” When terpenes and cannabinoids interact together, there is a heightened efficacy for medical marijuana patients. They termed this the “Entourage Effect.” Granddaddy Purple.

Terpenes 162

Terpenes Oil Strains Research and Development 162

Cannabis Chronicles

JANUARY 30, 2019

— writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. Not everyone in the field of cannabis and cannabinoid research was put off by the articles. In 2017, for example, Washington had 304.5

Marijuana 124

Marijuana Data Cannabinoids Medicine 124

The Cannigma

FEBRUARY 24, 2022

Endogenous cannabinoids like AEA and 2-AG regulate key body functions through their effects on receptors like CB 1 and CB 2 , as well as many others. The cannabis and hemp plants produce exogenous cannabinoids, or phytocannabinoids, that attach themselves to these receptors and others to mimic the effects of endogenous cannabinoids.

Cannabinoids 128

Cannabinoids Research and Development Conditions Cannabis 128

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.

Patients 107

Patients Clinical Trials Research and Development Treatment 107

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

FEBRUARY 25, 2021

Importantly, unlike most other terpenes, beta-caryophyllene can interact directly with the endocannabinoid system and has even been described as a dietary cannabinoid. The ECS is best known for interacting with cannabinoids from the cannabis plant, like THC and CBD, and is responsible for much of the plant’s therapeutic effects.

Terpenes 131

Terpenes Oil Cannabinoids Conditions 131

The Cannigma

MAY 28, 2021

When you smoke cannabis, the cannabinoids enter the bloodstream through your lungs and throat, while edibles are metabolized inside the gut. Topical solutions can activate the cannabinoid receptors in the epidermis, but they do not penetrate deeply into the skin, so they’re most effective for localized treatment.

Topical 140

Topical Oil Cannabinoids Cannabis 140

The Cannigma

JULY 1, 2021

The data will also help doctors and researchers boost their knowledge, and assist in the creation of better alternative health products, according to People Science. For example, certain uncommon sleep conditions and mental health diagnoses with psychoses will disqualify some applicants. And there’s still a lot to know.

Sleep 119

Sleep Edibles Research and Development Data 119

CannaMD

NOVEMBER 22, 2020

For those who suffer from migraine pain, the excruciating condition can be completely debilitating, impossible to manage without a dark room, a cool cloth over the eyes, and sublime silence. Patients used the app, Strainprint, which allowed data to be archived and studied.

Marijuana 116

Marijuana Treatment Patients Cannabinoids 116

Veriheal

AUGUST 15, 2022

The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Minor Cannabinoids vs. CBD and THC. This works out to around 40 people in every 10,000 who visit a general healthcare practice.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Human reports to date on the subject are largely anecdotal.

Data 114

Data Chronic Pain Patients Sleep 114

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis.

Research and Development 110

Research and Development Consumption Education Data 110

Veriheal

JANUARY 26, 2023

Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

JULY 13, 2021

Bo Gribbon, 20, went to the ER 11 times in 9 months for a condition that caused bouts of nonstop vomiting and screaming. By 2018, the number had risen to more than 120, according to data compiled by Dr. Brad Roberts, an emergency room physician at the hospital. He had never heard of marijuana producing a side effect like that.

Conditions 105

Conditions Data Cannabinoids Legislation 105

LifeCannMD

JANUARY 2, 2024

Medical Marijuana use has shown potential benefits in managing symptoms and improving the quality of life for individuals with various health conditions. Some animal-based studies go as far as to suggest cannabinoids might slow cancer cell growth.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

United Patients Group

MAY 17, 2023

Introduction Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects communication, social interactions and behaviors. Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention.

Sleep 105

Sleep Cannabinoids Patients CBD 105

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. 3,4] By observing the terpene profile, cannabinoid presence and potency, and quantity of standard biomolecules like lipids and waxes, scientists can identify different chemovars. Terpenes also interact with the cannabinoids to help the therapeutic benefits take effect!

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

CannaMD

OCTOBER 14, 2020

Israel’s research institutions have done it again — first they profiled cannabinoids (in the ’60s), then the endocannabinoid system (in the ’90s), and now they’re validating marijuana’s role in relieving the symptoms of ADHD. Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients.

Patients 98

Patients Marijuana Cannabinoids Consumption 98